z-logo
open-access-imgOpen Access
Reply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD ”
Author(s) -
Takahashi Hirokazu,
Anzai Keizo
Publication year - 2022
Publication title -
hepatology communications
Language(s) - English
Resource type - Journals
ISSN - 2471-254X
DOI - 10.1002/hep4.1996
Subject(s) - medicine , liraglutide , type 2 diabetes , dyslipidemia , gastroenterology , glycemic , nonalcoholic fatty liver disease , diabetes mellitus , steatosis , fatty liver , steatohepatitis , endocrinology , insulin , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom